Remove Engineering Remove Licensing Remove Marketing
article thumbnail

From FinOps Bean Counting to Value Harvesting: The Rise of Unit Economics

Perficient: Drug Development

Real technology spend includes observability tools, containers, data platforms, SaaS licensing, AI/ML, and peripheral services, sometimes hand-waved away as shadow IT or just life as part of an unavoidable cost center. Are Finance, Product, and Engineering collaborating on goals, reporting, and forecasting?

article thumbnail

From siloed data to breakthroughs: multimodal AI in drug discovery

Drug Target Review

The lack of collaboration between biologists, chemists, engineers and data scientists represents a significant barrier. He holds a master’s degree from University of Salerno in political sciences and marketing. Compartmentalised teams struggle to fully leverage multimodality, leading to suboptimal solutions.

Drugs 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ImaginAb Announces License and Supply Agreement with Pfizer for CD8 ImmunoPET Technology

The Pharma Data

a leading global provider of immuno-oncology imaging agents, today announced it has signed a new multi-year, non-exclusive license with Pfizer Inc. ImaginAb will receive license fees and payments for manufacturing and other support. LOS ANGELES , Jan. 7, 2021 /PRNewswire/ — ImaginAb Inc. , No other terms were disclosed.

article thumbnail

Spirulina’s role in shaping the future of preventative biologics

Drug Target Review

The antibiotic market has long faced significant barriers to innovation, with structural issues that make it difficult for new antibiotics to gain traction. As the demand for novel antibiotics remains limited due to the preference for cheaper generics, the market has struggled to incentivise much-needed breakthroughs.

article thumbnail

Beyond AEM: How Adobe Sensei Powers the Full Enterprise Experience

Perficient: Drug Development

But Sensei’s true value isnt limited to content operations, it’s the unified AI engine that quietly powers marketing intelligence, customer personalization, and even creative automation across Adobes enterprise ecosystem. Forecast campaign outcomes and key metrics with predictive analytics.

article thumbnail

BioDAOs are Community-Owned Research Translation Engines, Not Investment DAOs

Molecule Blog

Moving research from concept to market is like conducting a symphony — there are numerous players and stakeholders, each bringing their unique expertise to work in harmony and advance a project. If approved, the company can then market and distribute the therapeutic. How do BioDAOs differ from investment DAOs?

article thumbnail

Crescita Announces Licensing Agreement for Pliaglis; in China

The Pharma Data

Ltd (“Juyou”), a biotechnology company that develops and sells medical and cosmetic skincare products, for the commercialization and development of Pliaglis ® in mainland China (the “License Agreement”). million and US$1.8 For additional information, please visit [link].